Entero Healthcare Solutions Ltd - 544122 - Clarification On Investor Queries Relating To Profit Attributable To Owners Of The Company And Minority Interest For The Quarter Ended 31St March 2026
Entero Healthcare Solutions clarified investor queries regarding Q4 FY26 results. The company stated that profit attributable to owners was impacted by Rs. 11.4 crore in one-off costs, while an increase in non-controlling interest was due to the 51.51% acquisition of Anand Chemiceutics Private Limited.
May 28 2026 23:22:46
Entero Healthcare Solutions Limited
Entero Healthcare Solutions provided clarifications regarding its Q4 FY26 financial results. The company cited Rs. 11.4 crore in one-off costs from contract closure and provisioning charges affecting profit attributable to owners. Additionally, increased non-controlling interest resulted from a 51.51% stake acquisition in Anand Chemiceutics Private Limited.
May 28 2026 23:21:36
Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Entero Healthcare Solutions has made available the audio recording of its Investors/Analyst Earnings Call held for the audited financial results of Q4 FY26. The transcript will also be uploaded on the company's website in due course, providing full details of the discussion.
May 26 2026 15:28:00
Entero Healthcare Solutions Limited
Entero Healthcare's subsidiary, Sai Pharma Distributors, is set to acquire Vishal Surgicals for Rs. 6.3 crore in cash. This strategic acquisition will expand the company's pharmaceutical and surgical distribution business, with the target recording Rs. 11.6 crore turnover in FY25.
May 25 2026 23:24:53
Entero Healthcare Solutions Ltd - 544122 - The Board Approved The Re-Appointment Of Internal Auditor M/S. Ernst & Young LLP ('EY') For The Next Financial Year 2026-27.
Entero Healthcare Board approved its FY26 audited financial results, along with re-appointment of three Independent Directors and Internal Auditor. The board also fixed August 19, 2026 for its 8th Annual General Meeting and approved two small acquisitions.
May 25 2026 21:38:28
Entero Healthcare Solutions Ltd - 544122 - The Grant Of Fresh 7,300 (Seven Thousand Three Hundred) Employee Stock Options Under The Existing 'Entero Employee Stock Option Plan 2023'.
Entero Healthcare Board approved its FY26 audited financial results, along with re-appointment of three Independent Directors and Internal Auditor. The board also fixed August 19, 2026 for its 8th Annual General Meeting and approved two small acquisitions.
May 25 2026 21:31:42
Entero Healthcare Solutions Ltd - 544122 - Board Meeting Outcome for Outcome Of Board Meeting May 25, 2026
Entero Healthcare Solutions reported Q4 FY26 cons. revenue up 11.9% YoY to ₹1,909.93 Cr and net profit up 33.2% to ₹45.13 Cr. The board also re-appointed three Independent Directors for five-year terms, re-appointed Ernst & Young LLP as internal auditor for FY27, and approved the acquisition of Vishal Surgicals for up to ₹9.21 Cr, expanding its pharmaceutical distribution business.
May 25 2026 21:05:15
Entero Healthcare Solutions Ltd - 544122 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
ICICI Prudential Mutual Fund has significantly reduced its shareholding in Entero Healthcare Solutions from 5.015% to 2.161%. This disposal of 12.41 lakh shares occurred through open market transactions.
May 23 2026 10:40:31
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited's Board of Directors is scheduled to convene on May 25, 2026. The primary agenda includes the consideration and approval of the audited standalone and consolidated financial results for the fiscal year ended March 31, 2026.
May 18 2026 19:02:49
Entero Healthcare Solutions Ltd - 544122 - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results/Statements For The Quarter And Year Ended March 31, 2026.
Entero Healthcare Solutions' Board will convene on May 25, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
May 18 2026 18:59:37
Read More